Press Release: Replay : Replay and MD Anderson announce FDA clearance of IND application for first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy for multiple myeloma
Replay and MD Anderson announce FDA clearance of IND application for first-in-class T-Cell Receptor Natural Killer (TCR-NK) cell therapy for multiple myeloma
Read full article »
Co-Founder & CEO
Lachlan MacKinnon
Replay is a California-based gene therapy company that provides solutions such as genome editing and writing for the healthcare industry.
Read more